1. Home
  2. PLBY vs SGHT Comparison

PLBY vs SGHT Comparison

Compare PLBY & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLBY

PLBY Group Inc.

HOLD

Current Price

$1.35

Market Cap

204.4M

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$5.69

Market Cap

235.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLBY
SGHT
Founded
1953
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.4M
235.0M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
PLBY
SGHT
Price
$1.35
$5.69
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$3.00
$9.08
AVG Volume (30 Days)
654.9K
134.7K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
87.50
28.16
EPS
N/A
N/A
Revenue
$120,928,000.00
$77,363,000.00
Revenue This Year
$9.17
$11.67
Revenue Next Year
$7.10
$10.39
P/E Ratio
N/A
N/A
Revenue Growth
4.13
N/A
52 Week Low
$1.19
$3.11
52 Week High
$2.75
$9.24

Technical Indicators

Market Signals
Indicator
PLBY
SGHT
Relative Strength Index (RSI) 46.71 65.14
Support Level $1.23 $4.76
Resistance Level $1.48 $5.66
Average True Range (ATR) 0.08 0.31
MACD 0.01 0.06
Stochastic Oscillator 33.85 76.25

Price Performance

Historical Comparison
PLBY
SGHT

About PLBY PLBY Group Inc.

Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: